Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies.
about
Nanomaterials and autophagy: new insights in cancer treatmentSynergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells.Magnetite nanoparticles inhibit tumor growth and upregulate the expression of p53/p16 in Ehrlich solid carcinoma bearing miceStudy of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.Influence of synthetic superparamagnetic iron oxide on dendritic cells.Biocompatibility of Fe₃O₄@Au composite magnetic nanoparticles in vitro and in vivo.Daunorubicin-TiO2 nanocomposites as a "smart" pH-responsive drug delivery systemBactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.Gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1.Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesApoptosis selectively induced in BEL-7402 cells by folic acid-modified magnetic nanoparticles combined with 100 Hz magnetic fieldAnticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles.Interaction of cancer cells with magnetic nanoparticles modified by methacrylamido-folic acid.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.Fabrication and Cytotoxicity of Gemcitabine-Functionalized Magnetite Nanoparticles.Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.toxicity evaluation of silica-coated iron oxide nanoparticles in human SHSY5Y neuronal cells
P2860
Q28386642-D0C35C52-5222-40F1-B257-74921AA0B8D4Q34377965-1AC5B075-5F7C-4B92-9951-28C528EE6687Q34465935-78F5AD49-BAA7-45BB-BBA5-A9EA43C9151AQ35213046-778C7A35-ECB2-409C-A03F-FCFBA6E2918DQ35254464-CD885CB7-0895-4A58-95CE-E6A4F187E557Q35574688-44439593-FEF8-4E86-B331-9BE3AF4DC9D9Q35686927-F22BE51D-9289-4C62-9FE1-FC11A4108829Q35689986-63CFCD0B-3CE4-4FAB-93D8-28619812775FQ35787505-89DE1DFE-B61A-4797-A398-2495227CF151Q35979160-82EF54FB-C64D-4516-A7A0-C3CED8302779Q36289257-52A0153D-19CC-446D-975A-16A3D4F888D4Q37729751-7EA9ED96-E146-44AB-8DDB-E3F8BF84D920Q38885278-D2373E1D-0A27-45A3-8E3F-888E820C448CQ41895191-4D575604-3AC4-4A6C-82BC-447494D3EA57Q47440128-298D209D-FFC4-4BF9-A57F-61F8C595A17AQ47978647-8287FD1E-5773-4C3C-915E-BBB3A4F0EDEFQ55384208-6579E2AF-AFB8-4576-B72D-6E82967C90E5Q57377094-87F5A184-D377-4E4E-A14E-EFAFA3FF01E1
P2860
Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@ast
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@en
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@nl
type
label
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@ast
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@en
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@nl
prefLabel
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@ast
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@en
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@nl
P2093
P2860
P356
P1476
Biocompatibility of Fe3O4/DNR ...... t of hematologic malignancies.
@en
P2093
Baoan Chen
Chuanlu Xu
Jian Cheng
Jieyong Li
Mingming Yang
P2860
P304
P356
10.2147/IJN.S15660
P407
P577
2010-12-02T00:00:00Z